Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Jiangsu Hansoh Pharmaceutical Co., Ltd."
Count: 76
Selected: 0
| NCT ID | Title |
|---|
| NCT05779579 | Study of HS-10517 in Chinese Adult Participants | ||
| NCT05777109 | Comparing of the PK, PD, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Adults | ||
| NCT05480592 | A Study of HS-10380 in Chinese Participants | ||
| NCT05196971 | A Study To Evaluate The Safety, Tolerability And Pharmacokinetics of HS-10345 In Treatment-Resistant Depression | ||
| NCT04060511 | A Study of HS-10342 in Patients With Advanced Solid Tumor | ||
| NCT03903796 | Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus Infection | ||
| NCT03902691 | Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With Chronic Kidney Disease on Dialysis | ||
| NCT05740956 | A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors | ||
| NCT05430386 | Study of HS-10241 in Combination With Almonertinib in Patients With Locally Advanced or Metastatic NSCLC | ||
| NCT02981108 | A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLC | ||
| NCT03849768 | A Study to Evaluate Safety and Efficacy of HS-10296 as First-Line Treatment in Patients | ||
| NCT05367700 | A Study of HS-10382 in Patients With Chronic Myeloid Leukemia. | ||
| NCT03903809 | Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With NDD-CKD | ||
| NCT05504213 | A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer | ||
| NCT05116410 | A Study of HS-20094 in Healthy Participants | ||
| NCT05378178 | A PhaseⅠStudy of HS-10381 in Patients With Advanced Solid Tumors | ||
| NCT05429723 | First-in-Human Study to Investigate the Safety and Tolerability and Pharmacokinetics of HS-10383 | ||
| NCT05435274 | Phase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung Cancer | ||
| NCT05435248 | Hase 1/2 Study of HS-10375 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC) | ||
| NCT04951635 | A Phase III Study to Assess the Effects of Almonertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer | ||
| NCT04687241 | Almonertinib Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB Non-Small Cell Lung Cancer With EGFR-sensitive Mutations | ||
| NCT04631835 | Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer | ||
| NCT05367778 | Phase 1/2 Study of HS-10370 in Patients With Advanced Solid Tumors | ||
| NCT05367765 | A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase | ||
| NCT05353205 | A Study of the Efficacy and Safety of Flumatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase. | ||
| NCT05207787 | Phase 1 Study of the HS-10365 in Patients With Advanced Solid Tumors | ||
| NCT05195203 | A Study of HS-10353 in Chinese Participants. | ||
| NCT05044988 | A Study of HS-10342 in Chinese Patients With HR+/HER2- Advanced and/or Metastatic Breast Cancer | ||
| NCT04986436 | Phase I Study to Evaluate Safety, Tolerability, and Pharmacokinetics of HS-10360 in Healthy Subjects. | ||
| NCT04951648 | A Phase III Study to Assess the Efficacy and Safety of Almonertinib Versus Platinum-based Chemotherapy as First-line Therapy in Patients With Locally Advanced or Metastatic NSCLC Harbouring Uncommon EGFR Mutation | ||
| NCT04923906 | Aumolertinib With or Without Chemotherapy as 1st Line Treatment in Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Sensitizing EGFR Mutations | ||
| NCT04881006 | Bioequivalence of Dapagliflozin 10 mg Tablets Under Fed Conditions | ||
| NCT04880993 | Bioequivalence of Dapagliflozin 10 mg Tablets Under Fasting Conditions | ||
| NCT04804267 | Evaluation of Clinical Equivalence Between Two Linaclotide Products in the Treatment of Chronic Idiopathic Constipation | ||
| NCT04652297 | Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Administration of HS-10356 in Healthy Volunteers | ||
| NCT04477096 | Evaluation of Drug Interaction Between HS-10234 and Emtriccitabine | ||
| NCT04494373 | Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Adults | ||
| NCT04477057 | PhaseⅠStudy of the HS-10241 in Patients With Advanced Solid Tumors | ||
| NCT02204644 | The Study of the Efficacy and the Safety of Flumatinib vs Imatinib as First Line Treatment in Patients With CML | ||
| NCT03391440 | A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease | ||
| NCT03380793 | A Trial to Assess the Efficacy and Safety of Morinidazole in Patients With Appendicitis | ||
| NCT03243643 | Tolerability, Safety, Pharmacokinetics and Efficacy of HS-10241 Single Agent or Combined With Apatinib in Patients With Advanced Solid Tumors | ||
| NCT02477969 | Efficacy and Safety Study of PEX168 in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin | ||
| NCT02477865 | Efficacy and Safety Study of PEX168 in Monotherapy Diabetes Mellitus Type 2 Patients | ||
| NCT02472236 | Evaluate the Pharmacokinetics of Digoxin When Coadministered With PEX168 in Healthy Adult Subjects | ||
| NCT02461914 | Evaluate the Pharmacokinetics of Warfarin When Coadministered With PEX168 in Healthy Adult Subjects | ||
| NCT02447601 | Evaluate the Pharmacokinetics of Simvastatin When Coadministered With PEX168 in Healthy Adult Subjects | ||
| NCT02977364 | A Trial of C-met Kinase Inhibitor HS-10241 in Subjects With Advanced Solid Tumours | ||
| NCT02750007 | Tolerability to HS-20004 With Titration Administration in Type 2 Diabetic Patients | ||
| NCT02746315 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple s.c Doses HS-20004 in Healthy Chinese Volunteers |
